Atacicept not checked

Vera Therapeutics, Inc. · VT-001

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2 trial completes
Trials
4 active
5 in total · 4 in the EU
Targets
 

What this is

How it works
A decoy protein that soaks up a signal molecule before it can reach the body's cells.-cept: receptor molecules, native or modified WHO name stem
How it’s given
“Once weekly subcutaneous (SC) injections by prefilled syringe”In the company’s words, NCT04716231 on ClinicalTrials.gov
Tested for
Berger Disease (3 trials), IgA Nephropathy (IgAN) (2 trials), IgA Nephropathy, pMN, IgAN, Nephrotic Syndrome, MCD, FSGS and 1 more
Main trialPhase 3
“A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)”In the company’s words, NCT04716231 on ClinicalTrials.gov
Other names
VT-001

Other drugs for Berger Disease

All 39 drugs for Berger Disease

Coming up2

Changes1

Last 90 days

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 15 May 2025 Atacicept in Subjects With IgA Nephropathy
Phase 2Active, not recruiting 22 Sep 2026 Monthly Dosing of Atacicept in IgAN
Phase 2Recruiting Nov 2027 Atacicept in Multiple Glomerular Diseases
Phase 2Enrolling by invitation 21 May 2031 A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
Phase 3Withdrawn 15 Mar 2026 Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Atacicept

Following is part of Solo: you see every change to Atacicept the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in